|
|
||||||||

*
Centro Nacional de Biología Fundamental, Instituto de Salud Carlos III; and
Departamento de Inmunología, Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Cientificas, Madrid, Spain
It is known that certain type I membrane molecules (complement
receptors type 1 and 2) belonging to the regulators of complement
activation (RCA) family are involved in the regulation of B lymphocyte
activation. In contrast, only GPI-anchored RCA molecules (CD55) have
been described to be involved in T lymphocyte activation. In this
study, we describe a novel function for the mouse RCA type I membrane
protein Crry/p65 as a costimulatory molecule in CD4+ T cell
activation. This is shown by increased anti-CD3-induced
proliferation of CD4+ spleen T lymphocytes in the presence
of the Crry/p65-specific mAb P3D2. Furthermore, Ab-induced coligation
of Crry/p65 and CD3 favors IL-4 rather than IFN-
secretion in these
cells. Crry/p65 signaling was also observed regardless of additional
Ca2+, protein kinase C, or CD28-mediated costimuli.
Analysis of intracellular intermediaries shows that Crry/p65-CD3
coligation enhances certain TCR/CD3-mediated signals, producing
increased early tyrosine phosphorylation of many substrates and
enhanced activation of the mitogen-activated protein kinase,
extracellular signal-related kinase. These data fit well with the
association of Crry/p65 with the tyrosine kinase Lck found in T cell
lysates. The epitope recognized by the mAb P3D2 interferes with the
protective role of Crry/p65 on C3 deposition. The relationship between
protective function and costimulation by Crry/p65 is discussed. Our
results support a multifunctional role for Crry/p65 in T cells and
suggest new links between the natural and adaptive immune
responses.
This article has been cited by other articles:
![]() |
J. M. Rojo, E. Pini, G. Ojeda, R. Bello, C. Dong, R. A. Flavell, U. Dianzani, and P. Portoles CD4+ICOS+ T lymphocytes inhibit T cell activation 'in vitro' and attenuate autoimmune encephalitis 'in vivo' Int. Immunol., April 1, 2008; 20(4): 577 - 589. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Capasso, L. G. Durrant, M. Stacey, S. Gordon, J. Ramage, and I. Spendlove Costimulation via CD55 on Human CD4+ T Cells Mediated by CD97 J. Immunol., July 15, 2006; 177(2): 1070 - 1077. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Fairweather, S. Frisancho-Kiss, D. B. Njoku, J. F. Nyland, Z. Kaya, S. A. Yusung, S. E. Davis, J. A. Frisancho, M. A. Barrett, and N. R. Rose Complement Receptor 1 and 2 Deficiency Increases Coxsackievirus B3-Induced Myocarditis, Dilated Cardiomyopathy, and Heart Failure by Increasing Macrophages, IL-1beta, and Immune Complex Deposition in the Heart J. Immunol., March 15, 2006; 176(6): 3516 - 3524. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Jimenez-Perianez, G. Ojeda, G. Criado, A. Sanchez, E. Pini, J. Madrenas, J. M. Rojo, and P. Portoles Complement regulatory protein Crry/p65-mediated signaling in T lymphocytes: role of its cytoplasmic domain and partitioning into lipid rafts J. Leukoc. Biol., December 1, 2005; 78(6): 1386 - 1396. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Li, H. Patel, C. A. Farrar, R. E.G. Hargreaves, S. H. Sacks, and W. Zhou Complement Activation Regulates the Capacity of Proximal Tubular Epithelial Cell to Stimulate Alloreactive T Cell Response J. Am. Soc. Nephrol., September 1, 2004; 15(9): 2414 - 2422. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ohta, N. Kondor, N. Dohi, S. Tomlinson, M. Imai, V. M. Holers, H. Okada, and N. Okada Mouse Complement Receptor-Related Gene y/p65-Neutralized Tumor Vaccine Induces Antitumor Activity In Vivo J. Immunol., July 1, 2004; 173(1): 205 - 213. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Caragine, M. Imai, A. B. Frey, and S. Tomlinson Expression of rat complement control protein Crry on tumor cells inhibits rat natural killer cell-mediated cytotoxicity Blood, October 16, 2002; 100(9): 3304 - 3310. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zaffran, O. Destaing, A. Roux, S. Ory, T. Nheu, P. Jurdic, C. Rabourdin-Combe, and A. L. Astier CD46/CD3 Costimulation Induces Morphological Changes of Human T Cells and Activation of Vav, Rac, and Extracellular Signal-Regulated Kinase Mitogen-Activated Protein Kinase J. Immunol., December 15, 2001; 167(12): 6780 - 6785. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Drouin, D. B. Corry, J. Kildsgaard, and R. A. Wetsel Cutting Edge: The Absence of C3 Demonstrates a Role for Complement in Th2 Effector Functions in a Murine Model of Pulmonary Allergy J. Immunol., October 15, 2001; 167(8): 4141 - 4145. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Inoue, A. Fukui, M. Nomura, M. Matsumoto, K. Toyoshima, and T. Seya A Novel Chicken Membrane-Associated Complement Regulatory Protein: Molecular Cloning and Functional Characterization J. Immunol., January 1, 2001; 166(1): 424 - 431. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |